MedTrace Logo

Gestational Metabolic Abnormalities and Maternal and Infant Nutrition and Health

NCT01405547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 271

Last updated 2023-11-28

No results posted yet for this study

Summary

Childhood obesity is on the rise and is a major risk factor for type 2 diabetes later in life. Recent evidence indicates that abnormalities that increase risk for diabetes may be initiated early in infancy. Since the offspring of women with diabetes have an increased long-term risk for obesity and type 2 diabetes, the impact of maternal metabolic abnormalities on early nutrition and infant metabolic trajectories is of considerable interest. The purpose of the study is to investigate the impact of maternal nutrition and metabolic abnormalities in pregnancy on human milk and subsequently on infant health over the first year of life.

Conditions

Sponsors & Collaborators

  • Canadian Diabetes Association

    collaborator OTHER

  • Canadian Foundation for Dietetic Research (CFDR)

    collaborator OTHER

  • Anthony Hanley

    lead OTHER

Principal Investigators

  • Anthony Hanley, PhD · University of Toronto

  • Sylvia Ley, PhD · University of Toronto

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01405547 on ClinicalTrials.gov